Etomidate-®Lipuro 2mg/ml

Emulsion for injection. IV hypnotic with local and systemic tolerance

Etomidate-®Lipuro 2 mg/ml is indicated for the induction of general anaesthesia in adults, infants and toddlers older than 6 months, children and adolescents.

  • Reduced pain on injection 1
  • No thrombophlebitis 2
  • Less cardiovascular effects
  • Ready-to-use: No pre-dissolving or dilution necessary

Available in glass ampoule: 10 ml


Information may differ in your country. Before prescribing refer to nationally approved prescribing information.

1. Altmayer P., Grundmann U., Ziehmer M., Larsen R.; Comparative Study on Bioavailability and Side Effects of a New Galenic Formulation of Etomidate; Anästhesiol.
Intensivmed. Nofallmed. Schmerzther. 1993, 28: 415-419
2. A. Doenicke, A. Kugler, N. Vollmann, H. Suttmann, K. Taeger: Etomidat with a new solubilizer – Clinical and experimental investigations on venous tolerance and bioavailability. Anaesthesist 39, 475–480 (1990)
3. Doenicke A., Nebauer A.E., Hoernecke R., Mayer M., Roizen M.F.; Osmolalities of Propylene Glycol-Containing Drug Formulations for Parenteral Use. Should Propylene Glycol Be Used as a Solvent? Anesth Analg 1992, 75: 431-5
4. St. Pierre M., Dunkel, M., Rutherford A., Hering W.; Does etomidate increase postoperative nausea? A double-blind controlled comparison of etomidate in lipid emulsion with propofol for balanced anaesthesia. Eur J Anaesthesiol 2000, 17(10) : 634-41.
5. Thiemicke J., Doenicke A., Mückter H., Hoernicke R., Soukup J.; In uence of S(+) ketamine on endocrine and cardiovascular reaction during total intravenous anaesthesia with etomidate and propofol; Anästhesiologie & Intensivmedizin 2002, 43: 584-592.